CCSP counterbalances airway epithelial-driven neutrophilic chemotaxis.


Journal

The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460

Informations de publication

Date de publication:
07 2019
Historique:
received: 29 05 2018
accepted: 08 04 2019
pubmed: 27 4 2019
medline: 24 7 2020
entrez: 27 4 2019
Statut: epublish

Résumé

Club cell secretory protein (CCSP) knockout mice exhibit increased airway neutrophilia, as found in chronic obstructive pulmonary disease (COPD). We therefore investigated whether treating COPD airway epithelia with recombinant human CCSP (rhCCSP) could dampen exaggerated airway neutrophilia.Control, smoker and COPD air-liquid interface (ALI) cultures exposed to cigarette smoke extract (CSE) were treated with and without rhCCSP. The chemotactic properties of the supernatants were assessed using Dunn chambers. Neutrophil chemotaxis along recombinant human interleukin 8 (rhIL8) gradients (with and without rhCCSP) was also determined. rhCCSP-rhIL8 interactions were tested through co-immunoprecipitation, Biacore surface plasmon resonance (SPR) and

Identifiants

pubmed: 31023848
pii: 13993003.02408-2018
doi: 10.1183/13993003.02408-2018
pii:
doi:

Substances chimiques

CXCL8 protein, human 0
Interleukin-8 0
Recombinant Proteins 0
SCGB1A1 protein, human 0
Uteroglobin 9060-09-7

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright ©ERS 2019.

Déclaration de conflit d'intérêts

Conflict of interest: L. Knabe has nothing to disclose. Conflict of interest: A. Petit has nothing to disclose. Conflict of interest: C. Vernisse has nothing to disclose. Conflict of interest: J. Charriot has nothing to disclose. Conflict of interest: M. Pugnière has nothing to disclose. Conflict of interest: C. Henriquet has nothing to disclose. Conflict of interest: S. Sasorith has nothing to disclose. Conflict of interest: N. Molinari has nothing to disclose. Conflict of interest: P. Chanez has nothing to disclose. Conflict of interest: J-P. Berthet has nothing to disclose. Conflict of interest: C. Suehs has nothing to disclose. Conflict of interest: I. Vachier has nothing to disclose. Conflict of interest: E. Ahmed has nothing to disclose. Conflict of interest: A. Bourdin has nothing to disclose.

Auteurs

Lucie Knabe (L)

PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR 9214, Montpellier, France.
Dept of Respiratory Diseases, CHU Montpellier, University of Montpellier, Montpellier, France.

Aurélie Petit (A)

Dept of Respiratory Diseases, CHU Montpellier, University of Montpellier, Montpellier, France.

Charlotte Vernisse (C)

PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR 9214, Montpellier, France.
Dept of Respiratory Diseases, CHU Montpellier, University of Montpellier, Montpellier, France.

Jérémy Charriot (J)

Dept of Respiratory Diseases, CHU Montpellier, University of Montpellier, Montpellier, France.

Martine Pugnière (M)

IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France.

Corinne Henriquet (C)

IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France.

Souphatta Sasorith (S)

Laboratoire de Génétique Moléculaire, CHU Montpellier, University of Montpellier, Montpellier, France.

Nicolas Molinari (N)

IMAG U5149, Dept of Medical Information, CHU Montpellier, University of Montpellier, Montpellier, France.

Pascal Chanez (P)

C2VN - INSERM U1263 INRA 1260, AP-HM, Dept of Respiratory Diseases, Aix Marseille University, Marseille, France.

Jean-Philippe Berthet (JP)

Dept of Thoracic Surgery, CHU Montpellier, University of Montpellier, Montpellier, France.

Carey Suehs (C)

Dept of Respiratory Diseases, CHU Montpellier, University of Montpellier, Montpellier, France.

Isabelle Vachier (I)

Dept of Respiratory Diseases, CHU Montpellier, University of Montpellier, Montpellier, France.

Engi Ahmed (E)

Dept of Respiratory Diseases, CHU Montpellier, University of Montpellier, Montpellier, France.

Arnaud Bourdin (A)

PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR 9214, Montpellier, France a-bourdin@chu-montpellier.fr.
Dept of Respiratory Diseases, CHU Montpellier, University of Montpellier, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH